Early diagnostic value of survivin and its alternative splice variants in breast cancer. - Wikidata - wikimedia - TriplyDB

Early diagnostic value of survivin and its alternative splice variants in breast cancer.

Early diagnostic value of survivin and its alternative splice variants in breast cancer.

http://www.wikidata.org/entity/Q35118374

about

Breast Cancer-Derived Extracellular Vesicles: Characterization and Contribution to the Metastatic Phenotype The potential of tumor-derived exosomes for noninvasive cancer monitoring Localization and upregulation of survivin in cancer health disparities: a clinical perspective Extracellular vesicles: potential applications in cancer diagnosis, prognosis, and epidemiology.Evaluation of survivin splice variants in pituitary tumors.Expression of p16 and Survivin in gliomas and their correlation with cell proliferation The emerging role of exosomes in survivin secretion.Prognostic significance of pretreatment VEGF, survivin, and Smac/DIABLO serum levels in patients with serous ovarian carcinoma.Exosomes in development, metastasis and drug resistance of breast cancer.Suppressed diversity of survivin splicing in active rheumatoid arthritis.Computational Inferences of the Functions of Alternative/Noncanonical Splice Isoforms Specific to HER2+/ER-/PR- Breast Cancers, a Chromosome 17 C-HPP Study.Glioma-derived extracellular vesicles selectively suppress immune responses.Exosomes in diagnostic and therapeutic applications: biomarker, vaccine and RNA interference delivery vehicle.Tumour-derived exosomes: Tiny envelopes for big stories.Exosomes Derived from Breast Cancer Cells, Small Trojan Horses?Extracellular vesicles in breast cancer drug resistance and their clinical application.Survivin, a key player in cancer progression, increases in obesity and protects adipose tissue stem cells from apoptosis.Exosomes and breast cancer: a comprehensive review of novel therapeutic strategies from diagnosis to treatment.Exosomes in Cancer Diagnostics Peritoneal carcinomatosis: limits of diagnosis and the case for liquid biopsy.Role of exosomal proteins in cancer diagnosis Exosomal proteins as prognostic biomarkers in non-small cell lung cancer Pathologic significance of a novel oncoprotein in thyroid cancer progression.Alternative Splicing in Breast Cancer and the Potential Development of Therapeutic Tools.Exosomal proteins as potential markers of tumor diagnosis.Biological Functions and Current Advances in Isolation and Detection Strategies for Exosome Nanovesicles.Exosomes: Nanocarriers of Biological Messages.Chemoresistance in cancer cells: exosomes as potential regulators of therapeutic tumor heterogeneity.The influence of tumour-derived extracellular vesicles on local and distal metastatic dissemination.The Inner and Outer Qualities of Extracellular Vesicles for Translational Purposes in Breast Cancer.Exosomes in Cancer Liquid Biopsy: A Focus on Breast Cancer.Roles of Extracellular Vesicles in Metastatic Breast Cancer.Analysis of extracellular mRNA in human urine reveals splice variant biomarkers of muscular dystrophies Identification of Key Genes and Pathways in Triple-Negative Breast Cancer by Integrated Bioinformatics Analysis

P2860

Q26776113-C796148A-1D2E-448C-B15B-FED3C872FA7E Q26796396-5F00CB33-2771-4522-9AE6-DAB500655F6B Q26799719-F074FF6F-AC9C-4236-9D72-54B75546638B Q35440744-5E5AB7C4-B5AB-4495-A2AA-FE1176ABFD32 Q35582889-489CCA91-6E2E-48BC-AC85-836561E76227 Q35803811-4826DBD1-F351-4734-9DB5-EF588B535EB2 Q35810533-B6A00011-265E-4FCC-845C-2B35A960B139 Q35929423-E79C76F9-619F-4CCF-B5DA-A0CFB1D3F15A Q36016189-C1FD1F1E-CB46-49F3-A4D9-DFDEC5C2A21F Q36433351-7A89C671-767C-4C11-B880-3DF8AEA83493 Q36596946-129BD192-72FD-4715-896A-C6F142422518 Q36705896-9C0614FC-315F-4A20-92B0-D0F1795CE18D Q38264347-6948C3A8-64F0-4750-B765-9D3D55D02431 Q38449128-4A1065DE-A3B8-4EF6-BCDA-E9B392351F8D Q38541161-6A76AFD4-BBBF-41F3-81B7-0138CF10C332 Q38707369-E663D240-D476-4711-9274-748904E485C8 Q38778130-A072EF55-AF45-4362-B429-FA5CE2195B1A Q39041040-FDFCBA1B-5A63-44B5-A168-9B2EEB0D5B20 Q39085664-C888DE7C-2AA7-4208-8B35-DAE5B4BD4019 Q39246331-B3482D83-A7BD-4D4E-8D0B-CDF5E88CBD53 Q41556414-AECC967C-687B-4EBF-BBD0-5EFA77FC247E Q42282902-1760CDBD-93DA-48A5-8C75-80EEE3B2CB00 Q46228906-B3ACD1C8-EAAB-49EE-B9A9-3A21C35FDDE8 Q47110708-A8643FD5-FE87-42A4-9A18-46A2826A9F41 Q47159665-8B35ABEE-6B06-4FA3-B88B-6B6F450480F4 Q47250358-6117B157-E961-421B-A112-596BAA5CFFCE Q47763464-3EA884D6-2E94-4E99-9622-563109456B54 Q47957249-C65F3BBA-0CEC-4EB7-8F1F-68E17FE2859B Q49358083-1B8844CB-8430-4C8A-91CA-BE84CEB38132 Q52597634-6A25B358-D325-4C09-A400-F6C7C5C1963D Q52676618-5926FCBB-8C84-4ABF-8E3E-60C98C427367 Q55035055-D406113F-55FC-4020-8707-0435AE30730B Q56936089-BD17A837-B6AF-4D58-B4F1-207675837DD8 Q58803009-E2A84785-EC9A-47DD-A929-CE475477E188

P2860

Early diagnostic value of survivin and its alternative splice variants in breast cancer.

http://www.wikidata.org/entity/Q35118374

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Early diagnostic value of survivin and its alternative splice variants in breast cancer.

@ast

Early diagnostic value of survivin and its alternative splice variants in breast cancer.

@en

type

label

Early diagnostic value of survivin and its alternative splice variants in breast cancer.

@ast

Early diagnostic value of survivin and its alternative splice variants in breast cancer.

@en

prefLabel

Early diagnostic value of survivin and its alternative splice variants in breast cancer.

@ast

Early diagnostic value of survivin and its alternative splice variants in breast cancer.

@en

P1433

Q35118374-C573F915-EB44-4358-B098-06DA96BBB74D

P1476

Q35118374-60390740-42F3-4928-8993-CD5B2212F022

P2093

Q35118374-100C2F6F-24FE-4EC6-8F57-6B0212D93AAC

Q35118374-24281BDD-6C48-4C2C-959E-63DF15C09580

Q35118374-50D1B4AF-CE4A-48E8-ADA1-FE80E71A7036

Q35118374-631E1345-8EC7-43C2-802A-797F0869AF34

Q35118374-B03F32E1-1965-48D3-991A-F73B65A11905

Q35118374-C534494F-7A80-4909-9BBF-4C007B056D48

P2860

Q35118374-01204D15-A8C9-45EF-90FD-A5066B04C3AE

Q35118374-07B1585B-5696-46C0-BD72-2E9E6326AB43

Q35118374-1BDAF694-FADC-480D-8C22-9F1D4AB20502

Q35118374-1C19CD4A-C9C2-49C3-ADD2-702C8AABDE96

Q35118374-2A3B8DA9-9CDA-490E-BBE2-F845CC12DC2D

Q35118374-3EDA65B5-4870-4903-B857-B673E2CBDC54

Q35118374-4142BC48-D628-4443-A035-CD608BD65E91

Q35118374-42BEA3FF-D1D3-4DCB-9E08-B320595AD6EE

Q35118374-4FB56E5C-BDB5-4368-A9DF-075F7B12BFC9

Q35118374-50987620-845D-4ED7-82DC-56E633209384

P2888

Q35118374-BC4547E8-2606-452A-88F3-AA4A606BC008

P304

Q35118374-131BE9EA-82C5-4BD2-A9A1-77909884E7A9

P31

Q35118374-D172C69F-6439-4320-AF2F-910E8BF72184

P356

Q35118374-B429BA23-FBE8-4C32-99CB-F0C091DFC64B

P407

Q35118374-7ACD3DF0-4382-4CE3-92E0-6BA19C3A9EB5

P478

Q35118374-40021266-116B-4337-87AF-7519775664B6

P50

Q35118374-8E9F987F-A64C-410F-A281-CDF978A1E601

P577

Q35118374-7F8AD056-DD19-45EE-8C1F-3A0470D7342A

P5875

Q35118374-0907FAD9-224B-4BD7-9776-444502CADDF3

P6179

Q35118374-C551837D-758C-47F7-9059-2564DF795AAF

P698

Q35118374-F3FBB1EC-5494-43AA-8F1F-A910579F482F

P932

Q35118374-551510DD-F7DD-46E2-BF41-E567D0ED0924

P356

1471-2407-14-176

P1433

P1476

Early diagnostic value of survivin and its alternative splice variants in breast cancer.

@en

P2093

David Turay

http://www.w3.org/2001/XMLSchema#string

Heather Ferguson Bennit

http://www.w3.org/2001/XMLSchema#string

Mia Perez

http://www.w3.org/2001/XMLSchema#string

Saied Mirshahidi

http://www.w3.org/2001/XMLSchema#string

Salma Khan

http://www.w3.org/2001/XMLSchema#string

Yuan Yuan

http://www.w3.org/2001/XMLSchema#string

P2860

Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties

Prognostic role of survivin in bladder cancer: a systematic review and meta-analysis

Gene expression profiling predicts clinical outcome of breast cancer

Targeting survivin in cancer therapy

Survivin splice variants regulate the balance between proliferation and cell death

Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer

Mitotic arrest and apoptosis in breast cancer cells induced by Origanum majorana extract: upregulation of TNF-α and downregulation of survivin and mutant p53.

Proteome profiling of neuroblastoma-derived exosomes reveal the expression of proteins potentially involved in tumor progression

Survivin is released from cancer cells via exosomes.

Expression level of wild-type survivin in gastric cancer is an independent predictor of survival.

P2888

1471-2407-14-176

P304

176

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-14-176

http://www.w3.org/2001/XMLSchema#string

P407

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-03-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260762281

http://www.w3.org/2001/XMLSchema#string

P6179

1045551156

http://www.w3.org/2001/XMLSchema#string

P698

24620748

http://www.w3.org/2001/XMLSchema#string

P932

3995700

http://www.w3.org/2001/XMLSchema#string